Furthermore, BMSCs from OI patients have point mutations in COL1A1 or COL1A2, worse collagen processing, worse collagen stability, and worse collagen structure (Chamberlain et al. 2004). The gene discussed is COL1A2; the disease is osteogenesis imperfecta.